These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Use of Falicard and Sectral in patients with COPD and ischemic heart disease]. Khadzhipetrov N; Georgiev S Vutr Boles; 1983; 22(5):86-9. PubMed ID: 6673339 [TBL] [Abstract][Full Text] [Related]
26. Restoration of function in ischaemic myocardium by inosine [proceedings]. Kingaby RO; Lab MJ; Woollard K J Physiol; 1977 Oct; 272(1):102P-103P. PubMed ID: 592116 [No Abstract] [Full Text] [Related]
27. [The use of ramipril in treating patients with chronic heart failure]. Sinitsina II; Orlov VA; Zakharova GIu; Giliarevskiĭ SR; Ivasenko LA Ter Arkh; 1995; 67(5):75-7. PubMed ID: 7638788 [No Abstract] [Full Text] [Related]
28. [Effectiveness of the combined use of adrenergic beta receptor blockaders and long-acting nitrates in chronic ischemic heart disease]. Bragina GI Klin Med (Mosk); 1981 Nov; 59(11):36-42. PubMed ID: 6119395 [No Abstract] [Full Text] [Related]
29. [Effect of riboxin (inosine) on the chronobiological indices of purine metabolism in gout]. Loginova TK; Ershov IuA Revmatologiia (Mosk); 1985; (2):22-6. PubMed ID: 3901186 [No Abstract] [Full Text] [Related]
30. [Drug therapy of ischemic heart disease in middle-aged and elderly patients]. Ianovskaia MI Feldsher Akush; 1983; 48(2):16-20. PubMed ID: 6551254 [No Abstract] [Full Text] [Related]
31. [Effect of curantil and heparin on indices of microcirculatory and blood oxygen balance in ischemic heart disease]. Denisiuk VI Vrach Delo; 1982; (10):26-9. PubMed ID: 7179876 [No Abstract] [Full Text] [Related]
32. [Chronic vasodilator treatment in heart failure. II. Prazosin therapy]. Costică II; Dumitriu M; Cinteză M; Dăescu L; Bălan C Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(5):397-403. PubMed ID: 6151226 [No Abstract] [Full Text] [Related]
33. [Mechanisms of the hemodynamic effects of nonachlazine in ischemic heart disease patients]. Zaslavskaia RM; Zolotaia RD; Olevskiĭ IKh; Duda SG; Vilkovyskiĭ FA Farmakol Toksikol; 1986; 49(6):73-7. PubMed ID: 3817152 [TBL] [Abstract][Full Text] [Related]
34. [Characteristics of patients with ischemic heart disease under dispensary observation in a regional polyclinic and the evaluation of anti-angina therapy conducted under dispensary conditions]. Bekhbudova DA; Kokurina EV; Ostrovskaia TP; Bochkareva EV; Urumbaev RK Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1985; 8(1):95-100. PubMed ID: 3924078 [TBL] [Abstract][Full Text] [Related]
35. [Anti-arrhythmic effectiveness of isoptin in ischemic heart disease in the middle-aged and elderly]. Korkushko OV; Sarkisov KG; Butenko AG Vrach Delo; 1980 Jan; (1):30-5. PubMed ID: 7376578 [No Abstract] [Full Text] [Related]
36. [Effect of nitroglycerin on pulmonary gas exchange and ventilation-perfusion ratios in chronic ischemic heart disease]. Kobuliia BG; Kurashvili RB; Kavtaradze MN Klin Med (Mosk); 1984 Mar; 62(3):76-81. PubMed ID: 6425559 [No Abstract] [Full Text] [Related]
37. [More and more complicated combination therapy of ischemic heart disease]. Erhardt L; Herlitz J; Näslund U; Persson S Lakartidningen; 1989 Dec; 86(52):4595-7. PubMed ID: 2607868 [No Abstract] [Full Text] [Related]
39. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 3. Influence of the duration of therapy and co-medication on the therapeutic result. Secondary effects and discontinuation of therapy]. Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1873-9. PubMed ID: 4155950 [No Abstract] [Full Text] [Related]